{"id":"larotaxel-xrp9881","safety":{"commonSideEffects":[{"rate":"High (> 40%)","effect":"Neutropenia"}]},"_chembl":{"chemblId":"CHEMBL4279455","moleculeType":"Small molecule","molecularWeight":"831.91"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Larotaxel works by binding to tubulin and inhibiting its polymerization into microtubules, which are essential for cell division. This leads to the accumulation of cells in the G2/M phase and ultimately induces apoptosis in cancer cells. The exact mechanism of action is similar to other taxanes, such as paclitaxel and docetaxel.","oneSentence":"Larotaxel is a taxane dimer that inhibits microtubule dynamics, thereby inducing apoptosis in cancer cells.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:18:17.570Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Metastatic breast cancer"}]},"trialDetails":[{"nctId":"NCT00417209","phase":"PHASE3","title":"Larotaxel Compared To Continuous Administration of 5-FU in Advanced Pancreatic Cancer Patients Previously Treated With A Gemcitabine-Containing Regimen","status":"COMPLETED","sponsor":"Sanofi","startDate":"2006-12","conditions":"Pancreatic Neoplasms","enrollment":408},{"nctId":"NCT00327743","phase":"PHASE1, PHASE2","title":"Combination Study of a New Taxane and Capecitabine in Patients With Metastatic Breast Cancer","status":"COMPLETED","sponsor":"Sanofi","startDate":"2006-08","conditions":"Breast Cancer, Cancer","enrollment":34},{"nctId":"NCT00387907","phase":"PHASE2","title":"Study of Larotaxel in Combination With Weekly Herceptin® in Patients With HER2 Positive Metastatic Breast Cancer","status":"COMPLETED","sponsor":"Sanofi","startDate":"2006-10","conditions":"Advanced Breast Cancer, Breast Cancer, Metastatic Breast Cancer","enrollment":6},{"nctId":"NCT00625664","phase":"PHASE3","title":"Larotaxel + Cisplatin Versus Gemcitabine + Cisplatin in First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer","status":"COMPLETED","sponsor":"Sanofi","startDate":"2008-02","conditions":"Urinary Bladder Neoplasms","enrollment":337},{"nctId":"NCT00485979","phase":"PHASE2","title":"Treatment of Larotaxel/Docetaxel, +/- Trastuzumab, After Anthracycline-cyclophosphamide in Breast Cancer Patients","status":"COMPLETED","sponsor":"Sanofi","startDate":"2007-06","conditions":"Breast Neoplasms","enrollment":330},{"nctId":"NCT00386685","phase":"PHASE2","title":"XRP9881 in Combination With Trastuzumab in Metastatic Breast Cancer","status":"COMPLETED","sponsor":"Sanofi","startDate":"2006-07","conditions":"Breast Neoplasms","enrollment":51},{"nctId":"NCT00087958","phase":"PHASE2","title":"Intravenous RPR109881 in Male or Female Patients With Advanced Breast Cancer Who no Longer Respond to Anthracycline, Taxane and Capecitabine Treatment","status":"COMPLETED","sponsor":"Sanofi","startDate":"2004-08","conditions":"Breast Cancer","enrollment":168},{"nctId":"NCT00081796","phase":"PHASE3","title":"Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer","status":"COMPLETED","sponsor":"Sanofi","startDate":"2004-04","conditions":"Breast Cancer, Metastases","enrollment":438}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":4,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"larotaxel (XRP9881)","genericName":"larotaxel (XRP9881)","companyName":"Sanofi","companyId":"sanofi","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Larotaxel is a taxane dimer that inhibits microtubule dynamics, thereby inducing apoptosis in cancer cells. Used for Metastatic breast cancer.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}